Reach Us +1-217-403-9671
Probiotics: New Prophylaxis And Curing Weapon Against Diseases | 7520
ISSN: 2167-7689

Pharmaceutical Regulatory Affairs: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Probiotics: New prophylaxis and curing weapon against diseases

2nd International Conference and Exhibition on Pharmaceutical Regulatory Affairs

Abhinandan Ravsaheb Patil

Accepted Abstracts: Pharmaceut Reg Affairs

DOI: 10.4172/2167-7689.S1.008

Bacteria in this today world mostly considered as pathogenic. As every coin had two sides? bacteria though are pathogenic but still few are friendly essential for human growth and immunity. Such friendly bacteria are called Probiotics. L. acidophilus is one of probiotic bacterium found primarily in the small intestine where if introduced in sufficient colony serve as new prophylaxis and curing agent. Indian market lacks the quality uni-strain (containing one specific strain) product of the probiotics for the treatment and prophylaxis of the most of the disease. Commercially large use of antibiotics explored against the pathogenic micro-organism. By using the probiotics the hazardous of antibiotics can be minimized with the deletion of the side effects occurred due to heavy intake of xenobiotics drugs seen mostly in women?s and children as they are most sensitive and prone. The best mode to utilize healing quality of probiotics is to convert in dosage form. Technique require greater accuracy in case of the asepsis and maintenance of viability, This novel drug delivery system can also be beneficial for meeting the current needs with proper execution. Cfu (colony forming units) will give dry powder from culture media via process of encapsulation. To shape formulation capsule generation with unique dose adjustment will serve the Moto as new prophylaxis and curing agent against diseases even cancer. Inculcating the Onco (cancer cells) role is dramatically played by these wonder microbes by devising them in above described formulation.
Abhinandan R Patil is now studying M.Pharma 2nd year at the age of 24 years from Shivaji University Maharashtra. He is the Pharma director of Atmatara foundation and working as junior scientist (Kolhapur: India). He has participated and won prizes in many national conferences.